Biotricity, Inc. (BTCY)
OTCMKTS · Delayed Price · Currency is USD
0.5025
-0.0306 (-5.74%)
At close: Dec 2, 2025

Biotricity Statistics

Total Valuation

Biotricity has a market cap or net worth of 14.90 million. The enterprise value is 43.21 million.

Market Cap14.90M
Enterprise Value 43.21M

Important Dates

The last earnings date was Friday, November 14, 2025.

Earnings Date Nov 14, 2025
Ex-Dividend Date n/a

Share Statistics

Biotricity has 27.96 million shares outstanding. The number of shares has increased by 86.71% in one year.

Current Share Class 27.80M
Shares Outstanding 27.96M
Shares Change (YoY) +86.71%
Shares Change (QoQ) +1.84%
Owned by Insiders (%) 41.95%
Owned by Institutions (%) 0.17%
Float 15.57M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.99
PB Ratio -0.49
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -8.88
EV / Sales 2.87
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.23

Current Ratio 0.23
Quick Ratio 0.14
Debt / Equity n/a
Debt / EBITDA 186.14
Debt / FCF n/a
Interest Coverage -0.11

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -5.04%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 2.71%
Revenue Per Employee 327,859
Profits Per Employee -105,811
Employee Count46
Asset Turnover 2.60
Inventory Turnover 1.49

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +74.66% in the last 52 weeks. The beta is 1.34, so Biotricity's price volatility has been higher than the market average.

Beta (5Y) 1.34
52-Week Price Change +74.66%
50-Day Moving Average 0.56
200-Day Moving Average 0.51
Relative Strength Index (RSI) 46.54
Average Volume (20 Days) 23,716

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 3.12

Income Statement

In the last 12 months, Biotricity had revenue of 15.08 million and -4.87 million in losses. Loss per share was -0.19.

Revenue15.08M
Gross Profit 12.04M
Operating Income -468,684
Pretax Income -4.53M
Net Income -4.87M
EBITDA -462,731
EBIT -468,684
Loss Per Share -0.19
Full Income Statement

Balance Sheet

The company has 1.18 million in cash and 26.36 million in debt, giving a net cash position of -25.17 million or -0.90 per share.

Cash & Cash Equivalents 1.18M
Total Debt 26.36M
Net Cash -25.17M
Net Cash Per Share -0.90
Equity (Book Value) -30.28M
Book Value Per Share -1.24
Working Capital -18.08M
Full Balance Sheet

Cash Flow

Operating Cash Flow -446,637
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 79.84%, with operating and profit margins of -3.11% and -30.02%.

Gross Margin 79.84%
Operating Margin -3.11%
Pretax Margin -30.02%
Profit Margin -30.02%
EBITDA Margin -3.07%
EBIT Margin -3.11%
FCF Margin n/a

Dividends & Yields

Biotricity does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -86.71%
Shareholder Yield -86.71%
Earnings Yield -32.66%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on July 3, 2023. It was a reverse split with a ratio of 0.1666667.

Last Split Date Jul 3, 2023
Split Type Reverse
Split Ratio 0.1666667

Scores

Biotricity has an Altman Z-Score of -32.32 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -32.32
Piotroski F-Score 4